ARTICLE | Company News
OSI endocrine, cancer news
April 26, 2004 7:00 AM UTC
OSIP will invest a further $40 million in its majority-owned subsidiary, Prosidion Ltd. (Oxford, U.K.). The first installment of $10 million has been invested, which brings to 81% OSIP's stake in the...